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Abstract
The World Health Organization (WHO) has brought the growing epidemic of
antibiotic resistance bacteria to the attention of the public and has expressed the need for
the development of new methods of defense. In this direction, bioactive aldehyde essential
oils have been shown to effectively act as antibiotic and antifungal agents. These bioactive
compounds, when used in their pure form, are volatile and lack environmental stability. In
this thesis, we describe the synthesis of pro-antimicrobial networks via degradable acetals
(PANDAs) using thiol-ene photopolymerization. PANDAs were used as a new model for
the high loading and release of bioactive aldehyde-containing compounds via network
degradation in response to exposure to acidic pH. Herein, we report the synthesis of diallyl
p-chlorobenzaldehyde derived PANDAs to release the antimicrobial form of pchlorobenzaldehyde under mild conditions (pH 7.4/high humidity).

Keywords: Antibiotic resistance bacteria, essential oils, antimicrobial, thermoset, thio-ene
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CHAPTER ONE: INTRODUCTION
Every year, nearly 2 million people are infected with antibiotic resistant bacteria,
and of those infected, approximately 23,000 people die as reported by the Center for
Disease Control (CDC) in 2013. The threat of drug resistant bacteria will continue to grow
annually as antibiotics continue to lose their efficacy. Because of this threat, many efforts
have focused on the development and the discovery of alternative methods of defense
against these resistant bacteria. Among these efforts, aromatic terpene aldehydes – natural
constituents of plant-derived essential oils (EOs) – have been shown to exhibit both
antimicrobial and antifungal properties.1 However, the volatility, chemical instability, and
lack of water solubility of aromatic terpene aldehydes have imposed challenges to the
development of these materials as effective alternatives and/or supplements to antibiotics
derived from pharmaceutical pipelines.1 In an effort to overcome these challenges, methods
such as encapsulation of the EOs within colloidal suspensions or films have been utilized.1
However, low loading of the EO and uncontrolled burst release profiles observed in these
systems eliminate the possibility of controlled, extended release properties necessary for
effective antimicrobial applications.
CHAPTER TWO: LITERATURE REVIEW
The 1950s marked the golden age of antibiotics – a period when the discovery of
penicillin rapidly accelerated the investigation and development of many other classes of
antibiotics.2-3 However, after World War II, society was threatened by the emergence of
penicillin-resistant bacteria arising from the prolific use of antibiotics for the prevention
and treatment of bacterial infections.3 In the early sixties, methicillin was introduced as an
effective alternative to penicillin, and within the same decade, methicillin-resistant bacteria
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were identified in many patients.3 Today, the rate of discovery of resistant microbes has
vastly exceeded the discovery rate for methods to treat and mitigate these resistant
infections.2
Among the antibiotic resistant infections, there is not one specific type of bacteria
that is shown to be inherently prevalent amongst the human population. Both gram-positive
and gram-negative bacteria have developed resistance, and both pose an overall threat. 2
Staphylococcus aureus and Enterococcus, examples of gram-positive strains of bacteria,
together pose the largest threats to human health and longevity.2 Methicillin-resistant
Staphylococcus aureus (MRSA) alone results in more annual human deaths than homicide,
AIDS, Parkinson’s disease, and emphysema combined.2 Vancomycin is now employed as
a last resort treatment for MRSA. With time and use, vancomycin resistant strains of
bacteria have emerged with a mortality rate of 82%.2 Among the growing threat of
antibiotic resistance, gram-negative bacteria have specifically developed a resistance to all
available infection treatment options, thus rendering some infections virtually untreatable.2
E. coli results in one of the most common infections, urinary tract infection. As resistant
strains of bacteria become more prevalent, then a common treatable infection is likely to
become life threatening unless new treatments are discovered. Studies by Andrew Singer
have concluded that by the year 2050, resistant microbes will be more prevalent and will
cause more deaths annually than cancer.
As bacterial resistance increases, efforts from pharmaceutical and biotechnology
companies to develop solutions in this area have lagged. Spellberg et al. examined some of
the largest pharmaceutical and biotechnology companies finding that only one new novel
antibiotic agent is under development.4 Thus, to avoid complicated combinatorial synthesis
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of new synthetic libraries of compounds, scientists have turned to naturally occurring
compounds to combat the growing threat of antibiotic resistance. Among these compounds,
plant extracts, or essential oil (EOs), have shown antimicrobial efficacy against these
microbes. Since the applications of these EOs have arose, many different applications have
been discovered, such as antiviral, antioxidant, and cytotoxic activity.5-6
Among the many EOs available, there are different mechanism of action that result
in antimicrobial activity. One of the most prominent mechanisms is cell wall disruption –
a mechanism observed for tea tree oil.6 Essential oils are known to contain many
polyphenols and terpenoids, which have a high affinity toward proteins and glycoproteins
in the cellular membrane, thus enabling high permeation through the cell walls of bacteria.5
This mechanism of action is also applicable to gram-negative bacteria that have a layer of
lipopolysaccharide and protein which reduce the permeability of their membrane relative
to gram-positive bacteria.5 As the EOs permeate through the cell wall causing disruption,
the contents within the cell leak leading to bacterial cell death.5
However, utilizing EOs on their own poses several challenges such as high
volatility, chemical instability and a lack of water solubility.1 To avert these issues,
techniques have been developed to encapsulate EOs to improve their chemical stability and
provide controlled release. To obtain exemplary encapsulation, liposomes, coacervation,
spray drying, nanoemulsion, nanoprecipitation, nanoparticles, and co-crystallization can be
used.6 However some of these methods, such as liposome encapsulation, have reported
encapsulation efficiencies as low as ~ 4%, while also requiring the use of organics solvent
that could result in adverse reactions in a biological systems.6 Other researchers have
reported methods, such as nanoparticle encapsulation, that lead to poor release profiles,
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yielding only 23% release within 30 days within a pH 7 phosphate buffer solution.6
Chemical incorporation of the EOs within polymer matrices have shown higher efficiency
relative to encapsulation methods.
By chemically incorporating EO into polymers to form a poly(active) network,
higher loading and tailored release kinetics can be achieved, overcoming the complications
imposed by previous methods of encapsulation.7 Many polymer systems incorporate the
bioactive molecule onto the backbone of the primary polymer used, called the poly(active)
approach, and will be released via hydrolysis of the backbone of the polymer.8-9 As
discussed before, this method would cause controlled release of the bioactive, thus
preventing the passive burst release that is often provided by encapsulated and conjugated
release systems. The degradation rate of these systems can be controlled by the
composition of the bioactive molecule linkers that are used within the polymer backbone.7,
9

However, as the linkers degrade to release the bioactive, the residual polymer backbone

ultimately does not undergo biodegradation which will require removal from the system.7
In attempt to address the problems associated with EO sequestration, “polyactive”
networks can be used. These networks provide high loading of the active therapeutic
agents, and through formulation modification, the release rate of the therapeutic agent can
be tailored.7 Other researchers have proposed linear polyactives of phytochemicals as a
facile route to provide sustained release of a wide range of pharmaceuticals, such as antiinflammatories8,
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, antioxidants11-12, and anti-cancer compounds.13-14 While possible,

tailoring the rate of release of linear polyactives has its challenges due to the dependence
on many parameters, such as crystallinity, molecular weight, functionality and
hydrophilicity.15

iv

However, polyactive networks provide a more facile route of tailoring the release
kinetics by manipulation of the crosslink density, concentration of monomer, and monomer
molecular weight.16 It has recently been shown that biocompatible crosslinked polyactive
esters circumvent traditional linear polyactive release control by simple modification of
release rates and mechanical properties.17 While these crosslinked polyester do provide
biocompatibility and easier control of degradation rates, polymerization to form these
networks take longer than 24 hours at temperature above of 130°C, thus preventing in vivo
polymerization. In addition, the degradation of the ester bond results in release of acidic
compounds that will lead to a localized decrease in pH, causing an immune response.18 In
attempt to circumvent these challenges, polyactive acetal networks have shown to be a
promising alternative due to the mild reaction conditions and pH neutral byproducts.19
Herein, we describe the thiol-ene photopolymerization of pro-antimicrobial
networks via degradable acetals (PANDAs) from p-chlorobenzaldehyde (pCB). Thiol-ene
photopolymerization will allow for rapid and high conversion, minimum oxygen
inhibition, and mild reaction conditions, which will circumvent the indicated challenges
associated with sequestration of terpene aldehyde.20 Because of the step-growth activity of
thiol-ene photopolymerization, it will be ensured that at every crosslink junction, a
degradable pCB-derived acetal. This design will provide full degradation of the thiol-ene
network while also providing sustained release of an active antimicrobial compound, pCB,
and an inactive degradation byproduct.
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CHAPTER THREE: EXPERIMENTAL
Acyclic diallyl p-chlorobenzaldehyde acetal (pCBA) was synthesized from
p-chlorobenzaldehyde (pCB) via acid-catalyzed condensation of pCB with allyl alcohol.
Into a flame dried 250ml RBF, 3 Å molecular sieves (15g), pCB (10g, 71.14 mmol, 1
equiv), pTSOH (4.3g, 24.97 mmol, 0.35 equiv), allyl alcohol (16.52g, 284.6 mmol, 4
equiv.), and THF (50 ml). The resulting yellow solution was stirred for 24 hours and
quenched via the addition of TEA (19.8 mL, 142.3 mmol, 2 equiv), filtered from the
molecular sieves, and the solvent was removed on a rotary evaporator prior to the addition
to a silica gel column, eluted with a 1:9 ethyl acetate/hexanes. From the column, 8.3g
(48.9%) of pCBA was obtained, and purification verified by 1H NMR on a Varian Mercury
Plus 300 MHz NMR in Chloroform-d with the following chemical shifts: δ 7.46 (d, J = 8.4
Hz, 1H), 7.36 (d, J = 8.4 Hz, 1H), 5.95 (ddt, J = 16.2, 10.8, 5.6 Hz, 1H), 5.63 (d, J = 2.7
Hz, 1H), 5.33 (dt, J = 17.2, 1.8 Hz, 1H), 5.20 (dd, J = 10.5, 2.1 Hz, 1H), 4.06 (d, J = 5.1
Hz, 2 2H). 13C NMR (75 MHz, CDCl3) δ 136.97, 134.27, 128.41, 128.21, 116.96, 99.63,
66.06.
A solution of pCBA, prepared using the previously described method, was mixed
with pentaerythritol tetramercaptopropionate (PETMP) at 1:1 ratio of alkene:SH, with 4
wt.% of the photoinitiator, Darocure 1173, to make 100% loaded PANDA disks. To make
90% loaded PANDA disks, 1,3,5-triallyl-1,3,5-triazine-2,4,6-trione (TTT) was used as
another alkene source which contributes to 10% of the total amount of alkene functionality
in the system. These mixtures were pipetted onto a glass microscope slide previously
treated with Rain-X and containing two Teflon spacers (thickness:0.76 ± 0.02 mm) on both
ends of the glass slide. Another Rain-X treated slide was placed onto the first slide, thus
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providing an interstitial space to make the PANDA disks. The resulting samples were cured
via UV light for 20 minutes using an Omnicure S1000-1B equipped with a 100W mercury
lamp (λmax=365 nm, 320-500 nm filter) at an intensity of 200 mW cm−2. Kinetics of
polymerization was determined via real-time FTIR with a Nicolet 8700 FTIR spectrometer
with a KBr beam splitter and a MCT/A detector with a 320–500 nm filtered ultraviolet
light source.
The 25 mm3 PANDA disks were subsequently placed in a scintillation vial followed
by addition of 3 mL of pH 7.4 PBS solution and 15 mL of octanol. The octanol organic
layer was used to partition the aldehyde from the aqueous layer, a similar method used by
Carter and coworkers. 21 Immediately after addition of the octanol, 100 μL octanol aliquots
were removed from the scintillation vials to determine the concentration of the aldehyde.
Concentration was determined by measuring the UV-vis absorbance at 275 nm using a
BioTek Synergy 2 programmable microplate reader. After measurement of absorbance, the
same octanol aliquot was subsequently pipetted back into the corresponding scintillation
vials to maintain the same concentration. Aliquots were taken at the following time points:
t=0, 20, 24, 30, 48, 54, 72, 78, 102, 120 h. The experiments were performed with n=5, with
both the standard deviation and mean reported. After analysis of the concentration over the
course of 120 h, the data was then extrapolated from a standard calibration curve.
The antimicrobial activity of the PANDA disks was evaluated via zone of inhibition
(ZOI) assay with clinically isolated strains of the following bacteria: Escherichia coli
(serotype 95 O157:H7), Staphylococcus aureus RN6390, Burkholderia cenocepacia K562, and Pseudomonas aeruginosa PAO1. The overlay of the indicator organisms was made
by culturing the bacteria in Mueller Hinton II broth (MHB) at 37 °C overnight. From the

vii

overnight cultures, a dilution of 1:5 of cultured MHB and fresh MHB was made, and
subsequently mixed with molten soft agar to achieve a CFU concentration of ~108 CFU
mL-1. The soft agar consisted of the following per liter: 8g of sodium chloride, 10g Bacto
Tryptone, and 6g Difco agar. From the mixture of diluted solution and molten soft agar,
4mL was aliquoted onto Mueller Hinton II ager (MHA) plates and allowed to solidify.
Once solidified. 25 mm3 PANDA disks were overlaid on top of the soft agar and incubated
at 37 °C. After 30 hours of incubation, the ZOI was measured and reported as the radius
from the edge of the PANDA disk to the edge of the ZOI. For each strain, five replicates
were conducted and the mean and standard deviation of the ZOI is reported.
The rate of which the 90% pCBA loaded PANDA kill bacteria was conducted via
modified terminal dilution method. Two 90% PANDA disks were combined with 3mL of
~105 CFU/mL in a test tube. The resulting samples were incubated at 37°C at 200rmp for
30 hours. Six 100µL aliquots of the bacterial suspension was taken at the following time
points, after addition of the 90% pCBA loaded PANDA disks: 0, 2, 4, 8, 12, 24, 30 hours.
The aliquots were transferred into a 96-well microplate that was prefilled with 200µL of
MHB and serially diluted, which it was then incubated for 48hrs at the bacteria’s optimal
growth temperature. The turbidity of the MHB, after incubation, was measured via BioTek
Synergy 2 microplate reader at 600 nm. Optical density 0.05 was considered positive for
bacterial growth. The number of CFU was calculated by Equation 1, by using the final
dilution (TD) that had an optical density of 0.05.
𝐶𝐹𝑈 10 × 3𝑇𝐷
=
𝑚𝐿
1 𝑚𝐿

(1)

Minimum inhibitor concentration (MIC) was conducted via a modified broth
macrodilution method. PANDA disks ranging from sizes 5-50mm3 that had between 0.5viii

3mg/mL of pCB incorporated into the disk were added to test tubes along with 3 mL of
MHB bacterial solution at ~10 CFU mL-1. The resulting samples were then incubated at
37°C at 200rpm for 30 hours. The MHB bacterial solution served as a positive control,
whereas the uninoculated MHB was the negative control. Using a BioTek Synergy 2
programmable microplate reader optical density was conducted on the samples at 600nm
where an optical density of <0.05 was considered negative for bacterial growth.
A resistance assay was conducted using a similar method described by Haldar and
coworkers.22 The MIC for subsequent studies were conducted by making bacterial
solutions from sub-MIC (at MIC/2) of the disks. 3mL of a bacterial solution of ~105
CFU/mL, determined via optical density, was pipetted into 3 vials, followed by disks of
various sizes. The resulting samples were then incubated for 24 hours, then bacterial
solutions were again made using bacteria from the sub-MIC concentrations of the disks.
The resistance development was conducted twice, over 20 passages, where the MIC was
reported at each passage.
Fungal activity of the 90% loaded pCBA PANDA disks were tested against
Trichoderma harzianum and Candida albicans by use of the ZOI method. The fungal
cultures were adjusted to OD600 0.1 and 105 ppg/mL for C. albicans and T. harzianum,
respectfully. From the fungal cultures, 100L was spread on the surface of Mueller Hinton
II (MHA) plates and then a 25mm3 disk was placed. These resulting samples were then left
to incubate over the course of 72 hours at 30°C.
The cytotoxicity of 90% loaded pCBA PANDA disks were determined via a
standard literature procedure.23 Forty-eight hours prior to the study, the KB cells, from
Corning Incorporated, 100μL of 100,000cells/mL was pipetted into a 96 well plate. These
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cells were then treated with 50μL of
pCB, 50μL of PANDA degradation
byproducts, and a 3% DMSO
treatment served as a control. A
Vybrant MTT Cell Proliferation Kit
from

Invitrogen was used to

determined

cell

proliferation.

Figure 1. 1 H NMR of diallyl p-chlorobenzaldehyde
Before addition of 10μL of a 12mM acetal.
MTT reagent to each well of the 96
well plate, the cells were first
incubated for 30 hours. For an
additional 4 hours, the cells were
incubated, for which then the media
was removed and replaced by 50μL
Figure 2. 13C NMR of diallyl p-chlorobenzaldehyde.
of DMSO. Cell absorbance was
.
then determined via a Biotek Synergy2 MultiMode Microplate Reader, with a total of four
replicates.
CHAPTER FOUR: RESULTS AND DISCUSSION
The pCBA monomer was successfully synthesized at 49.8% yield via the acidcatalyzed condensation of pCB with allyl alcohol. The structure of the monomer was
confirmed via the presence of the acetal proton singlet observed at ~5.5ppm in the 1H NMR
spectrum (Figure 1). The acetal carbon was observed at 99.6 28 ppm by

13

C NMR

(Figure 2). The resulting product was then plated against clinically isolated strains of the

x

following bacteria: Escherichia coli (serotype 95 O157:H7), Staphylococcus aureus
RN6390, Burkholderia cenocepacia K56-2, and Pseudomonas aeruginosa PAO1. The
resulting pure pCBA exhibited no antibacterial properties due to the lack of an unprotected
aldehyde, thus no ZOI is observed, even at the highest tested concentration of 10mg/mL.
The degradation product, pCB, showed significant antibacterial properties, even at
0.5mg/mL. From this data, it shows that the acylic acetal serves as a pro-antimicrobial
compound, meaning that antibacterial efficacy is provided upon degradation into an
aldehyde.

Scheme 1. Synthesis of PANDAs and major degradation byproducts.
UV-curable PANDA resins were then formulated with a photoinitiator,
pentaerythritol tetramercaptopropionate (PETMP), and varied concentrations of pCBA
relative to non-degradable 1,3,5-triallyl-1,3,5-triazine-2,4,6-trione (TTT) with 1:1
xi

alkene:thiol mole stoichiometry (Scheme 1). According to Scheme 1, PANDAs are
molecularly designed to undergo complete degradation upon hydrolysis resulting in the
release of pCB as an active antimicrobial and antifungal agent, and the generation of
inactive low molecular weight degradation byproducts. The UV-photopolymerization of
PANDA disks from the 9:1 pCBA:TTT formulation resulted in transparent, low modulus
thermosets with a Tg of 0.5°C, as determined via dynamic mechanical analysis (Figure 3b).
The kinetics of this polymerization yielded rapid and high conversion of both the alkene
and thiol group, as determined via RT-FTIR (Figure 3a). Through altering of the feed ratio
of TTT to pCBA, different mechanical properties can be seen, such as difference in
flexibility, degradation, and Tg.
To explore the release of pCB from the 25 mm3 PANDA films, we submerged the
films in solutions consisting of two phases – an organic phase (octanol) and an aqueous
phase (PBS, pH 7.4 and pH 6.0). The organic phase was used to partition the aldehyde
from the aqueous layer. Aliquots from the organic phase over time were analyzed via UVvis spectroscopy to determine release as a function of time. Figure 3c shows the release
kinetics of the 90% loaded pCBA PANDA disks for pH 7.4 and 6.0 over 120 hours. A lag
time of ~20 hours can be seen at both tested pH values before pCB begins to release from
the degradable linkages within the polymer network, where 14% (1.07 mg/mL) and 53%
(4.19 mg/mL) at 24 and 48 hours, respectively at pH 7.4 and similar release at pH 6.0.
However, by 120 hours, only 72% release was observed at pH 7.4, whereas at pH 6.0 a
higher release occurred (80%). The higher release at lowered pH is due to the relative
instability of the acylic acetal against low pH. However, because of this lack of stability to
acidic environment, the hydrolysis of the acetal should be proportional to the concentration
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Figure 3. RT-FTIR cure kinetics, DMA, pCB release kinetics, and degradation behavior
of 90% loaded pCBA PANDA disks. (a) UV Conversion kinetics at cured at an intensity
200mW/cm2. (b) Representative thermomechanical plot. (c) pCB release at pH 6.0 and 7.4
in octanol/PBS. (d) PANDA degradation time-lapse characterized via optical microscopy.
of hydronium ions in the solution used rather than a simple increase in degradation kinetics.
This phenomena is attributed to the surface erosion behavior of the PANDA disks caused
by incorporation of pCBA into a hydrophobic network.24
The PANDA disks should exhibit surface erosion behavior when characterized by
optical microscopy. In the photo series of Figure 3d, 25 mm3 PANDA disks were
submerged in pH 7.4 PBS and monitored over time. By 1 hour, the surface of the PANDA
disk changed from translucent to opaque. At 24 hours, the PANDA disk shrank in size but
retained its shape, thus verifying surface erosion behavior. The observed surface erosion
xiii

behavior is typical of polyacetals and expected due to the hydrophobicity of the polymer
disks, as seen by its contact angle of ~90°.
PANDAs were designed for end-use as potential applications where antimicrobial
material is needed. Using ZOI experiments, the efficacy of the PANDA material was
evaluated against the following bacteria: Escherichia coli (serotype 95 O157:H7),
Staphylococcus aureus RN6390, Burkholderia cenocepacia K56-2, and Pseudomonas
aeruginosa PAO1. As shown in Figure 4a, the control PANDA disk, containing 0% loading
of pCBA, resulted in no zone of inhibition which is used as a negative control. Using pCBA
loadings from 60% to 100%, relative to TTT, showed that with increasing loading of the
pCBA a larger ZOI was observed. When >90%, the ZOI was seen to remain constant, thus
any subsequent antimicrobial studies were conducted using 90% pCBA loaded PANDA
disks. The efficacy of the material was further analyzed via terminal dilution assay to
determine kill kinetics (Figure 4b). Two 25 mm3 90% loaded pCBA PANDA disks showed
>5 log decrease in bacteria count in <12 hours, resulting in kill efficiencies of >99.999%.
To evaluate whether bacteria developed resistance to pCB, a resistance assay was
conducted and compared to the resistance assay of the commercially available antibiotic,
Tetracycline, against P. aeruginosa using serial passage mutagenesis assay. Figure 4c
shows the fold increase in MIC as a function of serial passages, and by the 20th passage,
the MIC for tetracycline nearly increased 10-fold, whereas the MIC for pCB remains
constant over 20 passages. Because there is no fold increase observed for the MIC of pCB,
P. aeruginosa is less likely to develop resistance, thus making this a practical method of
hindering the development and spreading of resistance bacteria.
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Figure 3. ZOI assay, Kill kinetics, Resistance Assay, Antifungal property analysis, Split
plate diffusion assay, Cytotoxcicity assay of 90% loaded pCBA PANDA disks. (a) ZOI
assay to show ZOI as a function of percent loading of pCBA. (b) Kill kinetics of four
representative bacteria via terminal dilution assay. (c) Resistance assay of 90% loaded
pCBA PANDA disks and tetracycline against P. aeruginosa. (d) ZOI diffusion assay of
0% and 90% loaded pCBA PANDA disks against T. harzianum and C. albicans. (e) Split
plate diffusion assay against C. albicans over 90 days. (f) Cytotoxicity assay with 2%
DMSO, pCB, and degraded 90% loaded pCBA PANDA disk.
xv

The antifungal properties of 25 mm3 90% loaded pCBA PANDA disks were
determined via ZOI against C. albicans and T. harizianum. As seen in Figure 4d, complete
inhibition of growth of both tested fungi was observed by the placement of 1 PANDA disk
onto the agar with platted fungi. The 0% loaded pCBA PANDA disk yielded no inhibition
of growth, thus the antifungal properties are exclusive to pCB. Knowing the volatility of
pCB, a split plate inhibition volatility assay was used to inhibit the growth of C. albicans
without contacting the PANDA material. A petri dish with a partition was used and on one
side, C. albicans was plated, and on the opposite side a 25 mm3 90% loaded pCBA PANDA
disk was plated. The petri dish was sealed and allowed to incubate for 30 days. Through
using one disk, only partial growth inhibition was observed, whereas when two was used
complete inhibition was observed (Figure 4e). As expected, 0% loaded pCBA PANDA
disk did not exhibit any inhibition of growth. Cytotoxicity of the PANDA material was
determined by using a model cell line and incubating the cells with the material. The chosen
cell line was KB cells which are derived from a glandular cancer of the cervix. These cells
were incubated in an aqueous solution containing a 90% loaded pCBA PANDA disk that
has been left to degrade for 7 days at pH 7.4, releasing 2.5 mg/mL pCB. Another solution
was used to incubate the cells and consisted of just pCB at 2.5mg/mL, and a control. As
seen from Figure 4f, there is no notable toxicity because the cell viability was maintained
above 90% observed, thus the material shows promise of possible biocompatibility.
In conclusion, we have successfully designed pro-antimicrobial networks via
degradable acetals. This material undergoes degradation in exposure to solutions of pH <8
and in atmosphere of mild humidity to release a bioactive compound that serves as a potent
and highly efficient antimicrobial agent against both fungi and bacteria. The released
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benzaldehyde as well as the other degradation byproducts exhibit high cytocompatibility,
thus allowing for future applications in the biomedical and food industries. We have also
demonstrated growth inhibition of C. albicans utilizing the volatility of essential oils,
eliminating the need for the material to be in direct contact with the fungi. Most
importantly, P. aeruginosa was unable to develop resistance to pCB in 20 serial passages,
whereas resistance was quickly developed toward the commercially available antibiotic,
tetracycline.
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